Literature DB >> 3796887

Anticholinesterase agents affect contrast gain of the cat cortical visual evoked potential.

E J DeBruyn, Y A Gajewski, A B Bonds.   

Abstract

The effects of the anticholinesterase agents physostigmine, pyridostigmine, diisopropylfluorophosphate and soman on the cortical visual evoked potential (VEP) were examined using phase reversed sine wave gratings of varying contrasts. All 4 agents decreased the slope (gain) of the response vs log contrast function while the intercept with the noise level (threshold, an indicator of contrast sensitivity) was unaffected. These results suggest that anticholinesterases modify the VEP by changing a contrast gain control mechanism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3796887     DOI: 10.1016/0304-3940(86)90639-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Contextual effects in fine spatial discriminations.

Authors:  Lynn A Olzak; Pentti I Laurinen
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2005-10       Impact factor: 2.129

2.  Component-specific effects of physostigmine on the cat visual evoked potential.

Authors:  K Arakawa; N S Peachey; G Celesia; G Rubboli
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

3.  The effects of physostigmine on the response characteristics of the cat visual evoked potential.

Authors:  G Rubboli; K Arakawa; G G Celesia; N S Peachey; H Tomoda
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

4.  Nonlinear dynamic causal models for fMRI.

Authors:  Klaas Enno Stephan; Lars Kasper; Lee M Harrison; Jean Daunizeau; Hanneke E M den Ouden; Michael Breakspear; Karl J Friston
Journal:  Neuroimage       Date:  2008-05-11       Impact factor: 6.556

5.  Dynamic causal modelling of precision and synaptic gain in visual perception - an EEG study.

Authors:  Harriet R Brown; Karl J Friston
Journal:  Neuroimage       Date:  2012-06-29       Impact factor: 6.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.